ACRO BIOMEDICAL CO., LTD. Increase (Decrease) in Accounts Payable
ACRO BIOMEDICAL CO., LTD. (ACBM) reported Increase (Decrease) in Accounts Payable of $7.50 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in accounts payable for the quarter ending 2021-12-31 was $10.13K, a 48.50% decline year-over-year.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in accounts payable for the quarter ending 2021-09-30 was $4.00K, a 0.00% change year-over-year.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in accounts payable for the quarter ending 2020-12-31 was $19.66K.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in accounts payable for the quarter ending 2020-09-30 was $4.00K.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in accounts payable for fiscal 2022 was $50.37K, a 3343.20% increase from fiscal 2021.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in accounts payable for fiscal 2021 was $1.46K, a 62.56% increase from fiscal 2020.
- ACRO BIOMEDICAL CO., LTD. increase (decrease) in accounts payable for fiscal 2020 was $900.00.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.50K 10-Q · filed 2026-08-14 | |||
| 2025-06-30 | -$58.97K 10-Q · filed 2026-08-14 | |||
| 2022-12-31 | $50.37K 10-K · filed 2023-07-21 | |||
| 2021-12-31 | $10.13K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-21 | $14.13K derived: sum of 2 quarters · filed 2023-07-21 | $1.46K 10-K · filed 2023-07-21 | |
| 2021-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | -$8.66K 10-Q · filed 2021-11-22 | ||
| 2021-06-30 | -$12.66K 10-Q · filed 2021-08-23 | |||
| 2020-12-31 | $19.66K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $23.66K derived: sum of 2 quarters · filed 2022-04-15 | $900.00 10-K · filed 2022-04-15 | |
| 2020-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | -$18.76K 10-Q · filed 2021-11-22 | ||
| 2020-06-30 | -$22.76K 10-Q · filed 2021-08-23 | |||
| 2017-03-31 | -$5.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-22 | $2.24K 10-Q · filed 2017-05-22 | ||
| 2016-12-31 | $7.27K 10-Q · filed 2017-02-14 | |||
| 2016-06-30 | $7.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-03 | $9.36K derived: sum of 2 quarters · filed 2017-05-22 | $10.18K 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $1.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-22 | $2.46K 10-Q · filed 2017-05-22 | ||
| 2015-12-31 | $823.00 10-Q · filed 2017-02-14 |